Indeed, combined gene therapy has recently shown significant promise in the treatment of animal models of heart failure, with combined transfer of apelin, fibroblast growth factor-2, and SERCA2a demonstrating increased gene expression in ischemic heart failure model [61]. Here, FGF2 is linked to heart failure.